The empirical within-trial analysis of the ASCENT cluster randomised trial. Funding: UNITAID (2019-33-ASCENT). Paper: "Equity, cost and disability adjusted life years of tuberculosis treatment supported by digital adherence technologies and differentiated care in Ethiopia: a trial-based distributional cost-effectiveness analysis". doi: 10.1101/2024.07.28.24310767. link: https://www.medrxiv.org/content/10.1101/2024.07.28.24310767v2.
-
Notifications
You must be signed in to change notification settings - Fork 0
The empirical within-trial analysis of the ASCENT cluster randomised trial. Accompanying paper "Equity, cost and disability adjusted life years of tuberculosis treatment supported by digital adherence technologies and differentiated care in Ethiopia: a trial-based distributional cost-effectiveness analysis".Funding: UNITAID (2019-33-ASCENT)
License
nicolacfoster/dcea.ana
About
The empirical within-trial analysis of the ASCENT cluster randomised trial. Accompanying paper "Equity, cost and disability adjusted life years of tuberculosis treatment supported by digital adherence technologies and differentiated care in Ethiopia: a trial-based distributional cost-effectiveness analysis".Funding: UNITAID (2019-33-ASCENT)
Resources
License
Stars
Watchers
Forks
Packages 0
No packages published